Biogen Pharma

Biogen_Pharma29 Apr 2024

Finance

₹

-0.01 (-0.88%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Biogen Pharma

Biogen Pharma

Finance

Biogen_Pharma29 Apr 2024

₹

-0.01 (-0.88%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
07-Jul-2003	S	Sub Division of existing equity share - from every one existing equity share of Rs.10/- each into ten equity shares of Re.1/- each. REDUCED PAID-UP VALUE - Re.1/- REDUCED PAID-UP VALUE W.E.F. - 15/07/2003.	21-Jul-2003
10-Jan-2024	BC	PFA PFA (As Per BSE Announcement Dated on 01/02/2024)	01-Feb-2024
10-Jan-2024	BC	PFA	25-Jan-2024
16-Jan-2024	BC	Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2024 inter alia to consider and approve Pursuant to Regulation 29 of t	22-Jan-2024
03-Jan-2024	BC	Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/01/2024 inter alia to consider and approve Pursuant to Regulation 29 of t	09-Jan-2024
09-Jan-2024	BC	Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company held tod	09-Jan-2024

No Rights has been declared by Biogen_Pharma

Book Closure

Record Date	Split Date	Purpose
01-Feb-2024	-	PFA PFA (As Per BSE Announcement Dated on 01/02/2024)
25-Jan-2024	01 Jan'1900	PFA
22-Jan-2024	-	Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2024 inter alia to consider and approve Pursuant to Regulation 29 of t
09-Jan-2024	-	Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/01/2024 inter alia to consider and approve Pursuant to Regulation 29 of t
09-Jan-2024	-	Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company held tod

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Biogen Pharmachem Industries Ltd ₹1.13(-0.01/-0.88%)	1.13	-0.01	73.74	75.38	56.50	1.32
Tata Investment Corporation Ltd ₹6,629.70(+0.75/0.01%)	6,629.70	+0.75	33,543.16	213.30	119.86	1.43
Alfred Herbert (India) Ltd ₹1,721.00(-35.10/-2.00%)	1,721.00	-35.10	132.52	147.63	137.24	1.31
Utique Enterprises Ltd ₹9.47(0.00/0.00%)	9.47	+0.00	52.72	97.29	78.92	0.75
Aravali Securities & Finance Ltd ₹6.45(+0.30/4.88%)	6.45	+0.30	9.77	57.69	0.00	-22.75
Bajaj Holdings & Investment Ltd ₹8,162.70(+12.70/0.16%)	8,162.70	+12.70	90,842.69	24.58	31.36	4.82

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.00	0.00	0.00	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	0.00	0.00	0.00	0.00	0.00
Other Operating Income	0.00	0.00	0.00	0.07	0.00	0.00
Other Income	0.09	0.76	0.75	0.00	0.33	2.05
Total Income	0.09	0.76	0.75	0.07	0.33	2.05
Total Expenditure	0.03	0.04	0.35	0.27	0.02	0.11
PBIDT	0.06	0.72	0.41	-0.20	0.30	1.94
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	0.06	0.72	0.41	-0.20	0.30	1.94
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	0.06	0.72	0.41	-0.20	0.30	1.94
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.06	0.72	0.41	-0.20	0.30	1.94

EPS (Unit Curr.)	0.00	0.01	0.01	0.00	0.00	0.03
EPS (Adj) (Unit Curr.)	0.00	0.01	0.01	0.00	0.00	0.03
Calculated EPS (Unit Curr.)	0.00	0.01	0.01	0.00	0.00	0.03
Calculated EPS (Adj) (Unit Curr.)	0.00	0.01	0.01	0.00	0.00	0.03
Calculated EPS (Ann.) (Unit Curr.)	0.00	0.04	0.02	-0.01	0.02	0.12
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.00	0.04	0.02	-0.01	0.02	0.12
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	65.26	65.26	65.26	65.26	65.26	65.26
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00	1.00	1.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PBDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PATM(%)	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	65.26	65.26	65.26	65.26	65.26	65.26
Reserves Total	-10.67	-11.13	-11.12	-9.51	-10.99	-10.98
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	54.59	54.13	54.14	55.75	54.27	54.28
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	0.00	0.00	0.00	0.31	0.63	0.01
Total Debt	0.00	0.00	0.00	0.31	0.63	0.01
Total Liabilities	54.59	54.13	54.14	56.06	54.90	54.29
APPLICATION OF FUNDS :
Gross Block	0.00	0.00	0.00	0.00	0.00	0.00
Less : Accumulated Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.00	0.00	0.00	0.00	0.00	0.00
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	8.85	6.95	9.49	6.45	6.25	3.52
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.00	0.00	0.00	0.00	0.00
Sundry Debtors	0.00	0.00	2.54	8.03	8.03	7.03
Cash and Bank	0.13	0.08	0.01	0.00	0.00	0.02
Loans and Advances	0.03	1.85	0.01	0.01	0.01	0.01
Total Current Assets	0.15	1.93	2.56	8.04	8.04	7.06
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.24	0.82	0.11	0.04	1.14	0.05
Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	0.24	0.82	0.11	0.04	1.14	0.05
Net Current Assets	-0.08	1.12	2.45	8.00	6.91	7.02
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	1.59	1.59
Net Deferred Tax	0.00	0.00	0.00	0.00	-1.59	-1.59
Total Assets	8.77	8.07	11.94	14.45	11.57	8.95
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.08	0.01	0.00	0.00	0.02
Net Cash from Operating Activities	1.70	1.40	3.95	-1.21	0.09
Net Cash Used In Investing Activities	-1.66	-1.32	-3.64	1.54	-0.72
Net Cash Used In Financing Activities	0.00	0.00	-0.31	-0.32	0.62
Net Inc./Dec In Cash And Cash Equivalents	0.05	0.08	0.00	0.00	-0.02
Cash And Cash Equivalents At End Of The Year	0.13	0.08	0.01	0.00	0.00

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

0.00%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

100.00%

**Promoter pledged shareholding 0.00%

About Biogen Pharmachem Industries Ltd

Biogen Pharmachem Industries Ltd is in the Finance sector, having a market capitalization of Rs. 73.74 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. 0.06 crores for the quarter ended December 2018. The company management includes Niraj Vaghela, Niraj Vaghela,Chandrakant Govingbhai Parmar,Khushboo Khandelwal,Harshadkumar Rathod,Narendrakumar Vaniya,Komalben Chauhan,CHHAYA PARMAR (Biogen Pharmachem Industries Ltd) among others.

Chairman

Niraj Vaghela

Registered office

Shop No 8 First Floor,Makers 1 Building Jawahar Road,Rajkot,Gujarat,360001

FAX :91-79-26765463

Background

Incorporation Year1995

Face Value₹1

Market Lot1

How to buy Biogen Pharma shares on nse?

To buy Biogen Pharma shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Biogen Pharma share price today?

The Biogen Pharma shares price on nse is Rs.1.13 today.

What is the market cap of Biogen Pharma shares on BSE ?

The company has a market capitalization of Rs.73.74Cr

What is the PE & PB ratio of Biogen Pharma shares ?

PE is 56.5 and PB is 1.32

What is the 52 Week High and Low of Biogen Pharma shares?

Biogen Pharma stock price high: Rs.1.85 Biogen Pharma stock price low: Rs.0.62